Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Reinvestment Rate
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Reinvestment Rate of 0.17x as of June 2026, reinvesting $28.82 Million (capex $28.82 Million ) from operating cash flow of $168.11 Million. See Biomarin Pharmaceutical Inc (BMRN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Biomarin Pharmaceutical Inc across 12 annual periods. For the full cash flow conversion analysis, see BMRN operating cash flow.
Annual Cash Flow Reinvestment Rate for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year capital reinvestment analysis for Biomarin Pharmaceutical Inc. See Biomarin Pharmaceutical Inc (BMRN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | $121.11 Million | $827.99 Million | $103.04 Million | ▼ -64.2% |
| 2024 | 0.41x | $233.91 Million | $572.84 Million | $97.42 Million | ▼ -68.8% |
| 2023 | 1.31x | $208.60 Million | $159.26 Million | $107.61 Million | ▲ +63.4% |
| 2022 | 0.80x | $140.99 Million | $175.90 Million | $120.96 Million | ▼ -49.7% |
| 2021 | 1.59x | $485.54 Million | $304.54 Million | $119.22 Million | ▼ -16.9% |
| 2020 | 1.92x | $163.69 Million | $85.36 Million | $137.52 Million | ▼ -63.5% |
| 2019 | 5.25x | $253.21 Million | $48.26 Million | $145.03 Million | ▼ -78.9% |
| 2018 | 24.92x | $503.60 Million | $20.21 Million | $144.62 Million | ▲ +124.3% |
| 2012 | 11.11x | $195.65 Million | $17.61 Million | $44.57 Million | ▼ -4.8% |
| 2011 | 11.67x | $218.88 Million | $18.75 Million | $154.22 Million | ▲ +219.9% |
| 2010 | 3.65x | $68.39 Million | $18.75 Million | $49.46 Million | ▲ +256.4% |
| 2009 | 1.02x | $89.80 Million | $87.73 Million | $89.80 Million | — |